Large-scale testing (Phase 3)Not Yet RecruitingNCT07202897
What this trial is testing
LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.
Who this might be right for
Hypertrophic Cardiomyopathy (HCM)
Rennes University Hospital 532